Correlation Between Coeptis Therapeutics and Hillstream Biopharma
Can any of the company-specific risk be diversified away by investing in both Coeptis Therapeutics and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coeptis Therapeutics and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coeptis Therapeutics and Hillstream Biopharma, you can compare the effects of market volatilities on Coeptis Therapeutics and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coeptis Therapeutics with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coeptis Therapeutics and Hillstream Biopharma.
Diversification Opportunities for Coeptis Therapeutics and Hillstream Biopharma
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Coeptis and Hillstream is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Coeptis Therapeutics and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Coeptis Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coeptis Therapeutics are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Coeptis Therapeutics i.e., Coeptis Therapeutics and Hillstream Biopharma go up and down completely randomly.
Pair Corralation between Coeptis Therapeutics and Hillstream Biopharma
If you would invest 39.00 in Hillstream Biopharma on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Coeptis Therapeutics vs. Hillstream Biopharma
Performance |
| Timeline |
| Coeptis Therapeutics |
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Coeptis Therapeutics and Hillstream Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coeptis Therapeutics and Hillstream Biopharma
The main advantage of trading using opposite Coeptis Therapeutics and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coeptis Therapeutics position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.The idea behind Coeptis Therapeutics and Hillstream Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |